Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study
The change of OAB symptoms and bothersome questionnaire scores after LiESWT treatment. (a) The bothersome questionnaire scores included overactive bladder (OAB) symptom scores (OABSS), international consultation on incontinence questionnaire-short form (ICIQ-SF), urogenital distress inventory-6- (UDI-6-) short form, and incontinence impact questionnaire-7 (IIQ-7) score at W4, W8, F1, and F3. (b) The improvement of questionnaire scores for overactive bladder (OAB) symptom after LiESWT treatment, including daytime frequency, nocturia, urgency, and urgency incontinence. ; compared to baseline (W0). W4: 4 weeks of LiESWT treatment; W8: 8 weeks of LiESWT treatment; F1: 1-month follow-up; F3: 3-month follow-up.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.